25 XP   0   0   10

Sam Chun Dang Pharm. Co. Ltd
Buy, Hold or Sell?

Let's analyse Sam Chun Dang Pharm. Co. Ltd together

PenkeI guess you are interested in Sam Chun Dang Pharm. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sam Chun Dang Pharm. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sam Chun Dang Pharm. Co. Ltd

I send you an email if I find something interesting about Sam Chun Dang Pharm. Co. Ltd.

Quick analysis of Sam Chun Dang Pharm. Co. Ltd (30 sec.)










What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.07
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
₩12,622.02
Expected worth in 1 year
₩17,105.80
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
₩4,567.05
Return On Investment
6.2%

For what price can you sell your share?

Current Price per Share
₩73,500.00
Expected price per share
₩61,100 - ₩83,600
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Sam Chun Dang Pharm. Co. Ltd (5 min.)




Live pricePrice per Share (EOD)

₩73,500.00

Intrinsic Value Per Share

₩-16,247.82 - ₩-2,001.53

Total Value Per Share

₩-3,625.80 - ₩10,620.49

2. Growth of Sam Chun Dang Pharm. Co. Ltd (5 min.)




Is Sam Chun Dang Pharm. Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$229m$141.2m$27.5m16.3%

How much money is Sam Chun Dang Pharm. Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$39.6k-$2.9m-98.7%
Net Profit Margin-7.8%-0.1%--

How much money comes from the company's main activities?

3. Financial Health of Sam Chun Dang Pharm. Co. Ltd (5 min.)




4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd? (5 min.)

Welcome investor! Sam Chun Dang Pharm. Co. Ltd's management wants to use your money to grow the business. In return you get a share of Sam Chun Dang Pharm. Co. Ltd.

What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd?

First you should know what it really means to hold a share of Sam Chun Dang Pharm. Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sam Chun Dang Pharm. Co. Ltd is ₩73,500. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sam Chun Dang Pharm. Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sam Chun Dang Pharm. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩12,622.02. Based on the TTM, the Book Value Change Per Share is ₩1,120.95 per quarter. Based on the YOY, the Book Value Change Per Share is ₩22.65 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩20.82 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sam Chun Dang Pharm. Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.420.0%-0.130.0%0.000.0%-0.030.0%0.040.0%
Usd Book Value Change Per Share3.150.0%0.900.0%0.020.0%0.120.0%0.170.0%
Usd Dividend Per Share0.000.0%0.020.0%0.060.0%0.040.0%0.050.0%
Usd Total Gains Per Share3.150.0%0.910.0%0.080.0%0.160.0%0.220.0%
Usd Price Per Share61.44-51.28-28.88-38.18-25.05-
Price to Earnings Ratio-36.88-527.32-75.10-121.57-74.79-
Price-to-Total Gains Ratio19.49-45.79--130.33--63.72-36.72-
Price to Book Ratio6.08-6.88-4.52-5.58-3.70-
Price-to-Total Gains Ratio19.49-45.79--130.33--63.72-36.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share58.8
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.04
Usd Book Value Change Per Share0.900.12
Usd Total Gains Per Share0.910.16
Gains per Quarter (17 shares)15.532.65
Gains per Year (17 shares)62.1110.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
116152381
2212211451612
3318317682423
45244238113234
56305300134045
67366362164856
78427424195667
89488486216478
910549548247189
10116106102779100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%11.09.00.055.0%30.09.01.075.0%33.09.01.076.7%
Book Value Change Per Share3.01.00.075.0%7.05.00.058.3%11.09.00.055.0%30.010.00.075.0%32.011.00.074.4%
Dividend per Share2.00.02.050.0%9.00.03.075.0%16.00.04.080.0%32.00.08.080.0%34.00.09.079.1%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%12.08.00.060.0%32.08.00.080.0%35.08.00.081.4%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Sam Chun Dang Pharm. Co. Ltd

About Sam Chun Dang Pharm. Co. Ltd

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-02-08 14:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Sam Chun Dang Pharm. Co. Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sam Chun Dang Pharm. Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of -24.4% means that ₩-0.24 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is -24.4%. The company is making a huge loss. -2
  • The TTM is -7.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-24.4%TTM-7.8%-16.6%
TTM-7.8%YOY-0.1%-7.6%
TTM-7.8%5Y-2.1%-5.6%
5Y-2.1%10Y3.1%-5.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.4%8.0%-32.4%
TTM-7.8%9.5%-17.3%
YOY-0.1%10.1%-10.2%
5Y-2.1%12.1%-14.2%
10Y3.1%11.8%-8.7%
1.1.2. Return on Assets

Shows how efficient Sam Chun Dang Pharm. Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • -2.9% Return on Assets means that Sam Chun Dang Pharm. Co. Ltd generated ₩-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is -2.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.9%TTM-0.9%-2.0%
TTM-0.9%YOY0.0%-0.9%
TTM-0.9%5Y-0.2%-0.7%
5Y-0.2%10Y0.7%-0.9%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%4.4%-7.3%
TTM-0.9%5.2%-6.1%
YOY0.0%5.1%-5.1%
5Y-0.2%5.0%-5.2%
10Y0.7%5.8%-5.1%
1.1.3. Return on Equity

Shows how efficient Sam Chun Dang Pharm. Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • -5.6% Return on Equity means Sam Chun Dang Pharm. Co. Ltd generated ₩-0.06 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is -5.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.6%TTM-1.8%-3.8%
TTM-1.8%YOY0.0%-1.8%
TTM-1.8%5Y-0.4%-1.4%
5Y-0.4%10Y1.0%-1.4%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.6%6.5%-12.1%
TTM-1.8%8.0%-9.8%
YOY0.0%6.8%-6.8%
5Y-0.4%7.4%-7.8%
10Y1.0%10.7%-9.7%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Sam Chun Dang Pharm. Co. Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sam Chun Dang Pharm. Co. Ltd is operating .

  • Measures how much profit Sam Chun Dang Pharm. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.0%-6.0%
TTM-5Y1.5%-1.5%
5Y1.5%10Y3.1%-1.6%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.2%-12.2%
TTM-11.7%-11.7%
YOY6.0%13.5%-7.5%
5Y1.5%11.1%-9.6%
10Y3.1%13.2%-10.1%
1.2.2. Operating Ratio

Measures how efficient Sam Chun Dang Pharm. Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.44 means that the operating costs are ₩1.44 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.443. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.211. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.443TTM1.211+0.232
TTM1.211YOY0.507+0.704
TTM1.2115Y0.840+0.371
5Y0.84010Y0.762+0.078
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4431.311+0.132
TTM1.2111.311-0.100
YOY0.5071.242-0.735
5Y0.8401.241-0.401
10Y0.7621.210-0.448
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Sam Chun Dang Pharm. Co. Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 1.78 means the company has ₩1.78 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.776. The company is able to pay all its short-term debts. +1
  • The TTM is 2.424. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.776TTM2.424-0.648
TTM2.424YOY3.892-1.468
TTM2.4245Y3.817-1.392
5Y3.81710Y2.672+1.145
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7762.077-0.301
TTM2.4242.028+0.396
YOY3.8922.173+1.719
5Y3.8172.048+1.769
10Y2.6722.053+0.619
1.3.2. Quick Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.08 means the company can pay off ₩1.08 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.083. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 2.605. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.083TTM2.605-1.522
TTM2.605YOY4.508-1.902
TTM2.6055Y3.650-1.044
5Y3.65010Y2.571+1.079
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0831.166-0.083
TTM2.6051.457+1.148
YOY4.5081.850+2.658
5Y3.6501.702+1.948
10Y2.5711.339+1.232
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Sam Chun Dang Pharm. Co. Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sam Chun Dang Pharm. Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.30 means that Sam Chun Dang Pharm. Co. Ltd assets are financed with 29.8% credit (debt) and the remaining percentage (100% - 29.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.298. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.467. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.298TTM0.467-0.169
TTM0.467YOY0.512-0.045
TTM0.4675Y0.430+0.037
5Y0.43010Y0.301+0.129
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2980.333-0.035
TTM0.4670.333+0.134
YOY0.5120.301+0.211
5Y0.4300.322+0.108
10Y0.3010.346-0.045
1.4.2. Debt to Equity Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 57.7% means that company has ₩0.58 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.577. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.969. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.969-0.393
TTM0.969YOY1.051-0.082
TTM0.9695Y0.830+0.139
5Y0.83010Y0.556+0.275
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5770.499+0.078
TTM0.9690.499+0.470
YOY1.0510.444+0.607
5Y0.8300.481+0.349
10Y0.5560.542+0.014
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Sam Chun Dang Pharm. Co. Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Sam Chun Dang Pharm. Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of -36.88 means the investor is paying ₩-36.88 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is -35.291. Based on the earnings, the company is expensive. -2
  • The MRQ is -36.876. Based on the earnings, the company is expensive. -2
  • The TTM is 527.325. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-35.291MRQ-36.876+1.585
MRQ-36.876TTM527.325-564.200
TTM527.325YOY75.095+452.230
TTM527.3255Y121.574+405.751
5Y121.57410Y74.793+46.781
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-35.29131.773-67.064
MRQ-36.87623.095-59.971
TTM527.32522.342+504.983
YOY75.09524.103+50.992
5Y121.57427.921+93.653
10Y74.79328.455+46.338
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is -103.128. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -107.758. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -66.909. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-103.128MRQ-107.758+4.630
MRQ-107.758TTM-66.909-40.849
TTM-66.909YOY-71.709+4.800
TTM-66.9095Y-34.085-32.824
5Y-34.08510Y-8.401-25.684
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD-103.12844.621-147.749
MRQ-107.75828.026-135.784
TTM-66.90931.298-98.207
YOY-71.70929.475-101.184
5Y-34.08525.820-59.905
10Y-8.40126.836-35.237
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sam Chun Dang Pharm. Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 6.08 means the investor is paying ₩6.08 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is 5.823. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.085. Based on the equity, the company is overpriced. -1
  • The TTM is 6.878. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.823MRQ6.085-0.261
MRQ6.085TTM6.878-0.793
TTM6.878YOY4.519+2.359
TTM6.8785Y5.578+1.300
5Y5.57810Y3.704+1.874
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD5.8233.849+1.974
MRQ6.0852.327+3.758
TTM6.8782.472+4.406
YOY4.5192.936+1.583
5Y5.5783.317+2.261
10Y3.7043.878-0.174
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sam Chun Dang Pharm. Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3940.7891120.946+252%22.654+17295%145.953+2600%212.431+1755%
Book Value Per Share--12622.0179414.078+34%7999.404+58%8529.782+48%8069.380+56%
Current Ratio--1.7762.424-27%3.892-54%3.817-53%2.672-34%
Debt To Asset Ratio--0.2980.467-36%0.512-42%0.430-31%0.301-1%
Debt To Equity Ratio--0.5770.969-40%1.051-45%0.830-31%0.556+4%
Dividend Per Share---20.815-100%79.114-100%49.011-100%58.397-100%
Eps---520.665-166.171-68%-2.248-100%-39.976-92%49.582-1150%
Free Cash Flow Per Share---178.177-287.787+62%-105.246-41%-81.878-54%143.726-224%
Free Cash Flow To Equity Per Share---178.177293.526-161%50.874-450%192.249-193%280.626-163%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max---2001.526--------
Intrinsic Value_10Y_min---16247.819--------
Intrinsic Value_1Y_max--463.297--------
Intrinsic Value_1Y_min---974.642--------
Intrinsic Value_3Y_max--886.079--------
Intrinsic Value_3Y_min---3511.767--------
Intrinsic Value_5Y_max--698.903--------
Intrinsic Value_5Y_min---6668.790--------
Market Cap1573326300000.000-11%1742479027200.0001436617315300.000+21%796656244000.000+119%1043275287260.000+67%681014527530.000+156%
Net Profit Margin---0.244-0.078-68%-0.001-100%-0.021-91%0.031-879%
Operating Margin----0%0.060-100%0.015-100%0.031-100%
Operating Ratio--1.4431.211+19%0.507+185%0.840+72%0.762+89%
Pb Ratio5.823-4%6.0856.878-12%4.519+35%5.578+9%3.704+64%
Pe Ratio-35.291+4%-36.876527.325-107%75.095-149%121.574-130%74.793-149%
Price Per Share73500.000-4%76800.00064100.000+20%36100.000+113%47730.000+61%31310.500+145%
Price To Free Cash Flow Ratio-103.128+4%-107.758-66.909-38%-71.709-33%-34.085-68%-8.401-92%
Price To Total Gains Ratio18.651-4%19.48845.789-57%-130.327+769%-63.724+427%36.725-47%
Quick Ratio--1.0832.605-58%4.508-76%3.650-70%2.571-58%
Return On Assets---0.029-0.009-68%0.000-99%-0.002-93%0.007-540%
Return On Equity---0.056-0.018-68%0.000-99%-0.004-93%0.010-644%
Total Gains Per Share--3940.7891141.761+245%101.768+3772%194.964+1921%270.828+1355%
Usd Book Value--229099992.224168791946.706+36%141224931.250+62%148940854.924+54%139620935.122+64%
Usd Book Value Change Per Share--3.1530.897+252%0.018+17295%0.117+2600%0.170+1755%
Usd Book Value Per Share--10.0987.531+34%6.400+58%6.824+48%6.456+56%
Usd Dividend Per Share---0.017-100%0.063-100%0.039-100%0.047-100%
Usd Eps---0.417-0.133-68%-0.002-100%-0.032-92%0.040-1150%
Usd Free Cash Flow---3234051.272-5132722.680+59%-1858059.286-43%-1470006.896-55%2427317.832-233%
Usd Free Cash Flow Per Share---0.143-0.230+62%-0.084-41%-0.066-54%0.115-224%
Usd Free Cash Flow To Equity Per Share---0.1430.235-161%0.041-450%0.154-193%0.225-163%
Usd Market Cap1258661040.000-11%1393983221.7601149293852.240+21%637324995.200+119%834620229.808+67%544811622.024+156%
Usd Price Per Share58.800-4%61.44051.280+20%28.880+113%38.184+61%25.048+145%
Usd Profit---9450505.776-3007559.346-68%-39689.082-100%-723665.797-92%829532.900-1239%
Usd Revenue--38754120.96036936301.722+5%35304013.200+10%35061952.677+11%31699865.579+22%
Usd Total Gains Per Share--3.1530.913+245%0.081+3772%0.156+1921%0.217+1355%
 EOD+2 -6MRQTTM+19 -15YOY+16 -195Y+16 -1910Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Sam Chun Dang Pharm. Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-35.291
Price to Book Ratio (EOD)Between0-15.823
Net Profit Margin (MRQ)Greater than0-0.244
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.083
Current Ratio (MRQ)Greater than11.776
Debt to Asset Ratio (MRQ)Less than10.298
Debt to Equity Ratio (MRQ)Less than10.577
Return on Equity (MRQ)Greater than0.15-0.056
Return on Assets (MRQ)Greater than0.05-0.029
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Sam Chun Dang Pharm. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5059.913
Ma 20Greater thanMa 5067,155.000
Ma 50Greater thanMa 10070,598.000
Ma 100Greater thanMa 20070,347.000
OpenGreater thanClose70,200.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets407,822,828
Total Liabilities121,447,838
Total Stockholder Equity210,585,565
 As reported
Total Liabilities 121,447,838
Total Stockholder Equity+ 210,585,565
Total Assets = 407,822,828

Assets

Total Assets407,822,828
Total Current Assets172,244,411
Long-term Assets235,578,417
Total Current Assets
Cash And Cash Equivalents 23,423,716
Short-term Investments 68,261,920
Net Receivables 36,801,268
Inventory 38,318,659
Other Current Assets 59,181
Total Current Assets  (as reported)172,244,411
Total Current Assets  (calculated)166,864,743
+/- 5,379,668
Long-term Assets
Property Plant Equipment 89,685,922
Goodwill 3,745,081
Intangible Assets 89,987,702
Long-term Assets  (as reported)235,578,417
Long-term Assets  (calculated)183,418,705
+/- 52,159,711

Liabilities & Shareholders' Equity

Total Current Liabilities96,978,778
Long-term Liabilities24,469,060
Total Stockholder Equity210,585,565
Total Current Liabilities
Short Long Term Debt 65,730,975
Accounts payable 4,886,308
Other Current Liabilities 0
Total Current Liabilities  (as reported)96,978,778
Total Current Liabilities  (calculated)70,617,284
+/- 26,361,494
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt5,642,022
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)24,469,060
Long-term Liabilities  (calculated)5,642,022
+/- 18,827,038
Total Stockholder Equity
Retained Earnings 101,209,072
Total Stockholder Equity (as reported)210,585,565
Total Stockholder Equity (calculated)101,209,072
+/- 109,376,492
Other
Capital Stock11,694,265
Common Stock Shares Outstanding 22,689
Net Debt 42,307,260
Net Invested Capital 276,316,540
Net Working Capital 75,265,634
Property Plant and Equipment Gross 154,432,822



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
118,204,920
123,443,031
127,827,531
155,378,650
159,831,378
162,511,808
168,442,151
172,490,847
171,174,146
173,017,326
180,350,978
184,260,203
187,802,246
193,611,970
199,295,326
205,113,463
210,940,399
215,540,228
222,891,131
235,143,417
241,361,802
244,596,118
242,169,841
261,158,440
265,390,933
271,276,486
283,175,879
290,150,966
291,086,043
290,127,871
308,298,061
317,078,866
345,331,804
345,546,175
343,639,552
345,996,602
361,470,284
365,302,011
375,762,736
372,793,050
393,813,672
403,547,425
407,822,828
407,822,828403,547,425393,813,672372,793,050375,762,736365,302,011361,470,284345,996,602343,639,552345,546,175345,331,804317,078,866308,298,061290,127,871291,086,043290,150,966283,175,879271,276,486265,390,933261,158,440242,169,841244,596,118241,361,802235,143,417222,891,131215,540,228210,940,399205,113,463199,295,326193,611,970187,802,246184,260,203180,350,978173,017,326171,174,146172,490,847168,442,151162,511,808159,831,378155,378,650127,827,531123,443,031118,204,920
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,953,841
128,516,381
131,206,711
137,417,373
131,979,749
128,207,154
142,271,889
146,058,904
151,409,701
162,119,366
162,492,554
163,085,830
159,756,047
176,227,738
166,527,651
173,235,567
186,685,799
172,247,307
168,919,766
173,982,849
175,258,759
178,153,354
157,749,140
173,557,812
171,516,196
172,244,411
172,244,411171,516,196173,557,812157,749,140178,153,354175,258,759173,982,849168,919,766172,247,307186,685,799173,235,567166,527,651176,227,738159,756,047163,085,830162,492,554162,119,366151,409,701146,058,904142,271,889128,207,154131,979,749137,417,373131,206,711128,516,381121,953,84100000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,131,091
57,372,191
61,906,493
56,567,833
55,290,147
41,847,555
51,471,447
46,687,623
45,933,148
59,698,170
60,191,032
54,780,694
46,917,144
51,781,148
58,882,279
60,186,193
77,660,259
63,350,269
28,117
32,317
52,467
34,903
13,953
38,350
37,141
23,423,716
23,423,71637,14138,35013,95334,90352,46732,31728,11763,350,26977,660,25960,186,19358,882,27951,781,14846,917,14454,780,69460,191,03259,698,17045,933,14846,687,62351,471,44741,847,55555,290,14756,567,83361,906,49357,372,19156,131,09100000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,206,227
1,206,227
1,177,095
7,947,335
7,947,335
19,000,000
29,292,930
31,300,000
38,300,000
38,300,000
39,084,293
0
0
0
38,030,725
47,060,497
36,928,640
36,914,100
47,911,629
64,881,830
59,604,497
63,587,975
64,147,606
72,189,768
67,163,970
68,261,920
68,261,92067,163,97072,189,76864,147,60663,587,97559,604,49764,881,83047,911,62936,914,10036,928,64047,060,49738,030,72500039,084,29338,300,00038,300,00031,300,00029,292,93019,000,0007,947,3357,947,3351,177,0951,206,2271,206,22700000000000000000
       Net Receivables 
29,571,415
29,754,763
29,988,525
30,720,418
31,235,757
31,950,528
31,134,079
33,406,655
31,085,768
30,426,673
31,633,826
32,352,192
32,867,183
33,931,473
35,381,930
38,218,555
37,182,281
36,535,734
41,570,351
38,863,500
39,682,429
39,752,457
41,560,672
37,082,484
43,711,552
41,778,619
31,698,686
38,900,372
43,321,474
45,764,936
45,174,495
36,540,037
39,506,239
39,318,984
37,113,232
38,589,321
40,711,007
40,406,893
46,339,632
35,460,946
35,617,338
36,574,365
36,801,268
36,801,26836,574,36535,617,33835,460,94646,339,63240,406,89340,711,00738,589,32137,113,23239,318,98439,506,23936,540,03745,174,49545,764,93643,321,47438,900,37231,698,68641,778,61943,711,55237,082,48441,560,67239,752,45739,682,42938,863,50041,570,35136,535,73437,182,28138,218,55535,381,93033,931,47332,867,18332,352,19231,633,82630,426,67331,085,76833,406,65531,134,07931,950,52831,235,75730,720,41829,988,52529,754,76329,571,415
       Other Current Assets 
579,930
726,293
1,160,000
584,510
1,900,354
760,273
889,898
903,469
736,646
833,240
756,160
738,745
1,296,236
1,325,637
991,024
970,883
629,299
310,039
687,070
1,183,845
3,922,945
1,038,495
1,057,721
661,267
831,041
1,032,678
521,058
798,708
783,694
3,626,192
2,982,583
2,589,036
2,482,349
4,846,374
4,539,926
260,253
160,790
253,510
2,273,506
56,188
56,636
56,379
59,181
59,18156,37956,63656,1882,273,506253,510160,790260,2534,539,9264,846,3742,482,3492,589,0362,982,5833,626,192783,694798,708521,0581,032,678831,041661,2671,057,7211,038,4953,922,9451,183,845687,070310,039629,299970,883991,0241,325,6371,296,236738,745756,160833,240736,646903,469889,898760,2731,900,354584,5101,160,000726,293579,930
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215,526,786
220,255,860
232,031,229
235,578,417
235,578,417232,031,229220,255,860215,526,786000000000000000000000000000000000000000
       Property Plant Equipment 
49,265,949
48,090,087
47,645,017
49,639,229
49,792,242
50,674,688
52,278,480
54,588,734
58,046,632
59,658,904
59,319,199
59,307,475
59,076,891
58,971,772
59,070,887
57,927,531
56,939,551
56,450,452
55,675,840
55,174,955
54,355,876
58,685,308
60,671,574
60,726,674
60,751,939
60,747,469
61,547,524
57,334,229
57,740,019
58,486,365
57,848,540
63,275,508
65,078,192
64,990,130
66,243,486
74,112,174
79,092,197
83,638,506
84,772,771
87,212,078
86,893,871
88,166,625
89,685,922
89,685,92288,166,62586,893,87187,212,07884,772,77183,638,50679,092,19774,112,17466,243,48664,990,13065,078,19263,275,50857,848,54058,486,36557,740,01957,334,22961,547,52460,747,46960,751,93960,726,67460,671,57458,685,30854,355,87655,174,95555,675,84056,450,45256,939,55157,927,53159,070,88758,971,77259,076,89159,307,47559,319,19959,658,90458,046,63254,588,73452,278,48050,674,68849,792,24249,639,22947,645,01748,090,08749,265,949
       Goodwill 
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,081
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,871,437
16,496,232
24,842,910
25,275,648
29,310,282
29,221,510
31,695,971
31,883,290
31,409,787
29,942,948
32,494,925
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000032,494,92529,942,94831,409,78731,883,29031,695,97129,221,51029,310,28225,275,64824,842,91016,496,23216,871,43700000000000000000
       Intangible Assets 
4,175,717
4,128,251
4,070,742
4,012,089
3,998,878
5,243,602
5,232,252
5,218,987
5,205,054
5,202,578
5,199,157
5,197,370
5,259,930
6,694,484
6,723,072
6,720,181
6,662,588
6,661,568
6,667,069
6,676,448
6,672,035
2,925,153
9,194,206
9,190,543
9,186,537
9,183,144
19,458,089
26,480,199
27,256,670
27,939,401
28,538,608
29,124,260
29,818,312
30,632,294
33,079,234
44,685,163
48,199,640
53,753,034
60,089,881
77,094,982
82,312,653
86,284,141
89,987,702
89,987,70286,284,14182,312,65377,094,98260,089,88153,753,03448,199,64044,685,16333,079,23430,632,29429,818,31229,124,26028,538,60827,939,40127,256,67026,480,19919,458,0899,183,1449,186,5379,190,5439,194,2062,925,1536,672,0356,676,4486,667,0696,661,5686,662,5886,720,1816,723,0726,694,4845,259,9305,197,3705,199,1575,202,5785,205,0545,218,9875,232,2525,243,6023,998,8784,012,0894,070,7424,128,2514,175,717
> Total Liabilities 
33,297,381
38,935,341
39,533,122
36,147,194
37,242,899
30,324,814
31,932,870
32,814,496
29,626,342
28,529,251
30,627,466
29,945,295
31,044,075
30,022,717
31,421,265
34,110,755
36,219,811
35,273,500
35,393,950
36,386,893
40,015,435
36,848,887
34,470,130
55,394,974
56,254,529
57,526,774
123,083,286
132,278,810
133,605,254
130,205,730
126,953,237
130,453,074
162,979,663
164,044,288
166,044,473
171,901,898
185,596,700
188,740,475
196,167,904
199,052,091
204,141,082
209,376,231
121,447,838
121,447,838209,376,231204,141,082199,052,091196,167,904188,740,475185,596,700171,901,898166,044,473164,044,288162,979,663130,453,074126,953,237130,205,730133,605,254132,278,810123,083,28657,526,77456,254,52955,394,97434,470,13036,848,88740,015,43536,386,89335,393,95035,273,50036,219,81134,110,75531,421,26530,022,71731,044,07529,945,29530,627,46628,529,25129,626,34232,814,49631,932,87030,324,81437,242,89936,147,19439,533,12238,935,34133,297,381
   > Total Current Liabilities 
21,841,006
19,977,188
20,265,217
29,786,312
30,766,701
24,781,644
25,787,529
26,547,663
22,765,178
20,535,512
21,629,741
21,713,551
22,323,590
22,076,685
22,157,547
26,146,746
27,694,330
26,369,253
25,477,002
23,699,293
26,131,194
26,804,339
24,895,175
38,419,138
37,809,987
38,788,437
40,509,142
45,205,983
44,181,731
39,581,659
34,539,595
23,658,314
56,518,434
32,570,765
51,589,443
54,019,011
52,621,432
49,962,302
31,656,376
38,159,521
90,259,702
91,994,977
96,978,778
96,978,77891,994,97790,259,70238,159,52131,656,37649,962,30252,621,43254,019,01151,589,44332,570,76556,518,43423,658,31434,539,59539,581,65944,181,73145,205,98340,509,14238,788,43737,809,98738,419,13824,895,17526,804,33926,131,19423,699,29325,477,00226,369,25327,694,33026,146,74622,157,54722,076,68522,323,59021,713,55121,629,74120,535,51222,765,17826,547,66325,787,52924,781,64430,766,70129,786,31220,265,21719,977,18821,841,006
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,195,635
7,365,073
5,336,425
5,244,812
3,000,000
3,000,000
0
10,867,279
0
2,877,077
2,439,279
2,591,934
2,818,187
12,622,162
2,011,004
1,820,327
1,989,944
2,273,210
1,579,730
1,980,246
3,051,205
2,928,845
2,755,729
22,814,876
22,932,345
0
022,932,34522,814,8762,755,7292,928,8453,051,2051,980,2461,579,7302,273,2101,989,9441,820,3272,011,00412,622,1622,818,1872,591,9342,439,2792,877,077010,867,27903,000,0003,000,0005,244,8125,336,4257,365,0738,195,63500000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,195,635
7,365,073
5,336,425
5,244,812
3,000,000
3,000,000
0
10,867,279
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,755,729
58,835,629
59,221,506
65,730,975
65,730,97559,221,50658,835,6292,755,7290000000000000010,867,27903,000,0003,000,0005,244,8125,336,4257,365,0738,195,63500000000000000000
       Accounts payable 
3,755,712
3,214,162
4,672,470
3,302,230
4,810,030
4,239,215
5,904,268
7,320,192
3,550,892
4,526,829
4,813,667
4,770,235
3,648,096
3,665,736
4,113,351
3,827,532
3,797,092
4,130,483
4,249,271
4,434,709
4,025,662
4,603,094
3,786,135
3,393,207
4,281,192
5,030,833
3,978,706
3,617,239
4,929,200
3,509,146
3,864,011
3,177,946
3,532,885
3,852,685
4,494,732
4,758,228
4,439,680
4,678,656
4,871,316
4,943,427
4,817,150
5,045,564
4,886,308
4,886,3085,045,5644,817,1504,943,4274,871,3164,678,6564,439,6804,758,2284,494,7323,852,6853,532,8853,177,9463,864,0113,509,1464,929,2003,617,2393,978,7065,030,8334,281,1923,393,2073,786,1354,603,0944,025,6624,434,7094,249,2714,130,4833,797,0923,827,5324,113,3513,665,7363,648,0964,770,2354,813,6674,526,8293,550,8927,320,1925,904,2684,239,2154,810,0303,302,2304,672,4703,214,1623,755,712
       Other Current Liabilities 
8,874,324
8,771,326
9,302,292
10,659,677
9,759,264
10,571,667
10,209,850
14,093,176
13,602,905
11,353,637
11,222,646
12,312,422
13,575,540
13,043,898
13,449,550
15,340,063
16,612,630
14,043,135
13,862,658
16,928,159
19,860,720
11,570,806
10,918,300
12,490,389
13,938,045
13,563,034
13,468,027
17,014,272
17,452,055
12,092,956
9,536,064
11,106,032
17,489,056
16,595,140
15,708,780
18,638,986
17,697,693
12,718,929
13,334,972
1,771,229
1,773,488
1,795,947
0
01,795,9471,773,4881,771,22913,334,97212,718,92917,697,69318,638,98615,708,78016,595,14017,489,05611,106,0329,536,06412,092,95617,452,05517,014,27213,468,02713,563,03413,938,04512,490,38910,918,30011,570,80619,860,72016,928,15913,862,65814,043,13516,612,63015,340,06313,449,55013,043,89813,575,54012,312,42211,222,64611,353,63713,602,90514,093,17610,209,85010,571,6679,759,26410,659,6779,302,2928,771,3268,874,324
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,474,742
41,923,351
43,658,882
24,469,060
24,469,06043,658,88241,923,35189,474,742000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,682,416
9,573,265
9,514,446
9,921,061
12,215,555
24,148,837
23,222,792
48,566,266
28,891,769
29,247,874
49,529,792
51,827,652
72,224,053
72,504,864
24,499,521
24,551,587
0
024,551,58724,499,52172,504,86472,224,05351,827,65249,529,79229,247,87428,891,76948,566,26623,222,79224,148,83712,215,5559,921,0619,514,4469,573,2657,682,41600000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,195,635
-7,365,073
-5,336,425
-5,244,812
-3,000,000
-3,000,000
0
-10,867,279
0
-2,877,077
-2,439,279
-2,591,934
-2,818,187
-12,622,162
-2,011,004
-1,820,327
-1,989,944
-2,273,210
-1,579,730
-1,980,246
-3,051,205
-2,928,845
3,256,616
-16,959,811
-16,972,566
5,642,022
5,642,022-16,972,566-16,959,8113,256,616-2,928,845-3,051,205-1,980,246-1,579,730-2,273,210-1,989,944-1,820,327-2,011,004-12,622,162-2,818,187-2,591,934-2,439,279-2,877,0770-10,867,2790-3,000,000-3,000,000-5,244,812-5,336,425-7,365,073-8,195,63500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,467,149
11,163,356
13,360,035
13,764,994
14,097,813
7,315,598
8,121,744
8,772,575
9,618,613
10,277,461
10,999,837
11,759,556
12,420,985
13,023,792
13,606,502
14,154,780
14,987,727
17,391,046
27,461,117
33,013,698
38,563,402
44,906,937
0
0
0
0
000044,906,93738,563,40233,013,69827,461,11717,391,04614,987,72714,154,78013,606,50213,023,79212,420,98511,759,55610,999,83710,277,4619,618,6138,772,5758,121,7447,315,59814,097,81313,764,99413,360,03511,163,3569,467,14900000000000000000
> Total Stockholder Equity
80,858,029
81,762,086
85,187,985
93,122,654
95,348,035
101,274,263
104,037,232
105,440,495
106,330,774
107,720,156
111,138,023
114,316,524
116,264,988
121,274,723
123,713,906
125,166,062
127,707,814
131,095,597
135,652,480
146,339,390
148,094,050
152,588,433
150,657,700
148,518,372
150,458,940
152,811,175
160,092,593
157,872,156
157,480,789
159,922,141
181,344,824
186,625,792
182,352,140
181,501,887
177,595,080
174,094,704
175,873,584
176,561,536
179,594,832
173,740,959
189,672,590
194,171,194
210,585,565
210,585,565194,171,194189,672,590173,740,959179,594,832176,561,536175,873,584174,094,704177,595,080181,501,887182,352,140186,625,792181,344,824159,922,141157,480,789157,872,156160,092,593152,811,175150,458,940148,518,372150,657,700152,588,433148,094,050146,339,390135,652,480131,095,597127,707,814125,166,062123,713,906121,274,723116,264,988114,316,524111,138,023107,720,156106,330,774105,440,495104,037,232101,274,26395,348,03593,122,65485,187,98581,762,08680,858,029
   Common Stock
10,000,000
10,000,000
10,000,000
10,000,000
10,000,000
10,526,454
10,526,454
10,526,454
10,526,454
10,526,454
10,618,583
10,618,583
10,618,583
10,671,228
10,671,228
11,000,262
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,533,397
11,533,397
0
011,533,39711,533,39711,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,000,26210,671,22810,671,22810,618,58310,618,58310,618,58310,526,45410,526,45410,526,45410,526,45410,526,45410,000,00010,000,00010,000,00010,000,00010,000,000
   Retained Earnings 
57,932,837
60,382,948
63,668,032
0
0
0
0
0
0
0
77,494,569
0
0
0
0
0
0
102,773,008
107,365,635
111,080,921
119,458,353
123,991,206
121,965,781
120,001,443
121,889,387
124,181,190
131,490,191
128,792,637
128,392,119
130,864,826
121,824,692
126,987,000
122,740,162
121,405,030
117,321,760
112,514,106
114,292,042
115,022,540
117,682,425
112,078,576
112,404,168
113,009,663
101,209,072
101,209,072113,009,663112,404,168112,078,576117,682,425115,022,540114,292,042112,514,106117,321,760121,405,030122,740,162126,987,000121,824,692130,864,826128,392,119128,792,637131,490,191124,181,190121,889,387120,001,443121,965,781123,991,206119,458,353111,080,921107,365,635102,773,00800000077,494,569000000063,668,03260,382,94857,932,837
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,595,514
16,595,514
16,609,132
16,525,339
46,911,312
46,911,312
46,911,312
46,911,312
46,911,312
46,911,312
46,997,034
46,997,034
47,194,174
47,282,563
62,502,818
66,648,927
0
066,648,92762,502,81847,282,56347,194,17446,997,03446,997,03446,911,31246,911,31246,911,31246,911,31246,911,31246,911,31216,525,33916,609,13216,595,51416,595,51400000000000000000000000000
   Treasury Stock0000000-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327000-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-135,181
-170,925
6,385,250
-237,522
-275,992
-181,300
-356,290
-303,666
-243,234
3,213,125
206,300
201,832
254,271
3,194,725
118,661
91,847
576,725
753,188
2,060,466
1,975,688
1,933,143
2,109,414
3,605,892
3,681,935
3,693,067
0
03,693,0673,681,9353,605,8922,109,4141,933,1431,975,6882,060,466753,188576,72591,847118,6613,194,725254,271201,832206,3003,213,125-243,234-303,666-356,290-181,300-275,992-237,5226,385,250-170,925-135,18100000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.